Growth Metrics

GeneDx Holdings (WGS) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$52.3 million.

  • GeneDx Holdings' Income from Continuing Operations rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • As of FY2024, GeneDx Holdings' Income from Continuing Operations stood at -$52.3 million, which was up 70.25% from -$175.8 million recorded in FY2023.
  • In the past 5 years, GeneDx Holdings' Income from Continuing Operations ranged from a high of -$52.3 million in FY2024 and a low of -$548.9 million during FY2022.
  • Over the past 3 years, GeneDx Holdings' median Income from Continuing Operations value was -$175.8 million (recorded in 2023), while the average stood at -$259.0 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 712.48% in 2020, then surged by 70.25% in 2024.
  • Yearly analysis of 5 years shows GeneDx Holdings' Income from Continuing Operations stood at -$241.3 million in 2020, then dropped by 1.68% to -$245.4 million in 2021, then slumped by 123.70% to -$548.9 million in 2022, then surged by 67.98% to -$175.8 million in 2023, then skyrocketed by 70.25% to -$52.3 million in 2024.